Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2012 / Cilt: 22 - Sayı: 2

Çocukluk çaği akut lenfoblastik Lösemi’li olgularda moleküler sitogenetik bulgular

Molecular cytogenetic findings in cases with childhood acute lymphoblastic leukemia

Pages
67–72
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our study, we found that the t(12.21) translocation was the most common abnormality in minimal and standard risk groups, whereas the 9p21 deletion was the most common abnormality among high-risk patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and is usually associated with numerical and structural chromosomal changes.
📊
Key Findings & Data:Although some of these changes are accepted as favorable or poor prognostic factors, the prognostic effects of others have not been well determined.
💡
Conclusion & Impact:In our study, we found that the t(12.21) translocation was the most common abnormality in minimal and standard risk groups, whereas the 9p21 deletion was the most common abnormality among high-risk patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and is usually associated with numerical and structural chromosomal changes. Although some of these changes are accepted as favorable or poor prognostic factors, the prognostic effects of others have not been well determined. In our study, we aimed to present the chromosomal changes in cases with childhood ALL and their ratios in hematologic risk groups. Thirty four patients with childhood ALL were included in the study. Subjects were diagnosed with fluorescence in situ hybridization (FISH) analysis by using standard translocation, deletion and aneuploidy probes. The chromosomal changes obtained from our analysis were classified into hematologic risk groups and their ratios were evaluated. In our study, we found that the t(12.21) translocation was the most common abnormality in minimal and standard risk groups, whereas the 9p21 deletion was the most common abnormality among high-risk patients.

Özet

Akut Lenfoblastik Lösemi (ALL) çocukluk çağında görülen en yaygın malignite olup sayısal ve yapısal kromozomal değişiklikler ile birlikte görülebilmektedir.Bu değişikliklerin bazılarının iyi ya da kötü prognostik belirteç kabul edilirken bazılarının ise prognostik etkileri tam bilinmemektedir. Çalışmamızda, çocukluk çağı ALL vakalarında saptanan kromozomal değişiklikler ile hematoljik risk gruplarındaki oranlarını vermeyi amaçladık. Çalışmaya tanı almış çocukluk çağı akut lenfoblastik lösemili 34 olgu alındı. Olgulara, ALL açısından değer taşıyan standart translokasyon, delesyon ve aneuploidi probları kullanılarak floresan in situ hibridizasyon (FISH) analizleri yapıldı. Saptanan kromozomal değişiklikler vakaların hematolojik risk gruplarına göre sınıflandırılarak oranları değerlendirildi. Çalışmamı zda, 9p21 delesyonu yüksek riskli hastalar arasında en sık görülen anomali iken t (12.21) translokasyonu minimal ve standart risk grubunda en sık görülen anomali olduğunu bulduk.

🔖

Cite This Article

KARKUCAK, M., GÖRÜKMEZ, O., YAKUT, T., BAYTAN, B., GORUKMEZ, O., GUNES, A. M. (2012). Çocukluk çaği akut lenfoblastik Lösemi’li olgularda moleküler sitogenetik bulgular. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 22 - Sayı: 2, 67–72. https://ajindex.com/articles/323193

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Woo HY, Kim DW, Park H, et al. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. J Korean Med Sci 20: 36- 41, 2005
  2. Avet-Loiseau H. FISH analysis at diagnosis in acute lymphoblastic leukemia. Leuk Lymphoma 33: 441- 449, 1999
  3. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81: 2237-2251,1993
  4. Moorman AV, Clark R, Farrell M, et al. Probes for hidden hyperdiploidy in acute lymphoblastic leukemia. Genes Chromosomes Cancer 16: 40-45,1996
  5. Pui C-H, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76: 1449- 1463,1990
  6. Mertens F, Johansson B, Mitelman F. Dichotomy of hyperdiploid acute lymphoblastic leukemia on the basis of the distribution of gained chromosomes. Cancer Genet Cytogenet 92: 8-10,1996
  7. Harrison CJ. The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Rev. 15: 49-59,2001
  8. Rubnitz JE, Pui C-H. Childhood acute lymphoblastic leukemia. Oncologist 2: 374–380,1997
  9. Zemanova Z, Michalova K, Sindelarova L, et al. Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukemia. Leuk Res 29: 273-281,2005
  10. Yakut T, Gulten T. Çocuklukçağı Lösemilerindeki Genetik Değişiklikler ve Klinik Önemi. Uludağ Üniversitesi Tıp Fakültesi Dergisi 31: 57-62, 2005
  11. Kim M, Yim SH, Cho NS, et al. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood Blineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet Cytogenet. 195: 59-65, 2009
  12. Zhang L, Parkhurst JB, Kern WF, et al. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia. Chin Med J 116: 1298-1303, 2003
  13. Adolfo A, Ferrando A, Thomas L, et al. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 37: 381-395, 2000
  14. Arnland B, Glassman MD. Chromosomal abnormalitics in acute leukemia. Clin Lab Med 20: 39-48, 2000
  15. Harrison CJ. The genetics of childhood acute lymphoblastic leukaemia. Baillieres Best Pract Res Clin Haematol.13: 427-39, 2000
  16. McLean TW, Ringold S, Neuberg D, et al. TEL/AML-1 dimerizes and is